Showing 20 of 35 recruiting trials for “endometrial-stromal-sarcoma”
Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
Safety of Robotic Surgery for GISTs at Special Anatomic Sites
🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Feb 2026View details ↗
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
RCT of EFTR Versus STER for GIST Treatment
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
A Study of Olverembatinib in SDH-deficient GIST.
RecruitingNCT06431451 ↗
The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients with Advanced GISTs
Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
👨⚕️ Jun Zhang, First Affiliated Hospital of Chongqing Medical University📍 1 site📅 Started May 2024View details ↗
Imatinib TDM in GIST
MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT
👨⚕️ Liming Zhang, M.D., Peking University People's Hospital📍 1 site📅 Started Jan 2024View details ↗
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor
The Efficacy and Safety of Temozolomide in SDH-deficient GIST
RecruitingNCT05867901 ↗
Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence
RecruitingNCT05938309 ↗
A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors
RecruitingNCT05804331 ↗
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →